Vardenafil

Pediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alfuzosin, Alpha blockers, Amyl Nitrite, Antifungals, Antihypertensives, Atazanavir, Boceprevir, Bosentan, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Conivaptan, CYP3A4 inhibitors, Darunavir, Dasatinib, Disopyramide, Doxazosin, Erythromycin, Etravirine, Fosamprenavir, Grapefruit Juice, High-fat foods, Indinavir, Itraconazole, Ketoconazole, Lopinavir, Macrolide antibiotics, Nelfinavir, Nicorandil, Nifedipine, Nitrates, Nitroglycerin, Nitroprusside, Phosphodiesterase 5 inhibitors, Protease inhibitors, Riociguat, Ritonavir, Sapropterin, Saquinavir, Tamsulosin, Telaprevir, Terazosin, Tipranavir

PREGNANCY CATEGORY: B
not indicated for use in women

Our database has 74 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RESPIRATORY.
OTHER.


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top